Latest news
CVRx Reports Second Quarter 2026 Financial and Operating Results - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTMoleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients - GlobeNewswireGlobeNewswire · Fri, 31 Jul 2026 12:10:00 GMTNovo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation - GlobeNewswireGlobeNewswire · Fri, 31 Jul 2026 07:00:00 GMTREGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, - GlobeNewswireGlobeNewswire · Thu, 30 Jul 2026 23:49:10 GMTIonis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% – HBSS - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 16:46:12 GMTCVRx to Present at Canaccord Genuity's 46th Annual Growth Conference - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 12:30:00 GMT